Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

80.50
EUR
-1.50
(-1.83%)
-3.46EPS
4.36BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

Q4 FY2025 · Press release

March 9, 2026 · 4 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this press release
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents